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Introduction
Nonviral approaches to gene therapy rely on the transfer of DNA complexed with liposomes. Liposomes usually contain two lipids, one a cationic amphiphile and the other, a neutral phospholipid. The polycationic cores of liposomes supplied by compounds with high cationiccharge-density potential such as spermine, polylysine or polyethyleneimine are able ionically to condense plasmid DNA. The lipid part, which interacts with and/or destabilizes membranes, permits the fusion and entry of the DNA-liposome complex. However, DNA delivery by liposomes is an inefficient process. The major mechanism of entry of the DNA-liposome complex seems to be endocytosis, 1,2 but the delivered DNA becomes trapped in intracellular vesicles and is largely destroyed by lysosomal enzymes. Even if part of the transfected DNA is liberated into the cytoplasm through mass action effect, only a small fraction of this DNA is subsequently found in the nucleus. 2 In our previous work we showed that an individual adenovirus protein, penton base, which forms nanoparticles called dodecahedrons can function as a gene transfer system. 3 In the adenovirus particle, the fiber protein attaches to the penton base through its N-terminus.
peptide can attach with a fibre-like N-terminus to the base protein and fix and condense DNA with the Cterminal polylysines. Such a tertiary system comprising dodecahedron, peptide and attached DNA enters cells and transfers DNA into the nucleus, resulting in gene expression. 3 Optimal transfection was observed at a ratio of peptide to DNA of about 1 (w/w). Subsequently, we have found that when the amount of peptide is increased such that the ratio of peptide to DNA is between 4 and 6, efficient gene transfer is observed in the absence of dodecahedron. Peptide alone has proved to be an efficient gene transfer vector, and its activity is characterized in this paper.
Structural proteins of adenovirus are synthesized in the cytoplasm during a late phase of the adenovirus life cycle and are transported to the nucleus where virus assembly takes place. Transport to the nucleus of proteins larger than about 40 kDa is an energy-dependent process. This process requires the presence of a nuclear localisation signal (NLS) sequence on the protein for transport through the nuclear pore complex. 5, 6 An NLS was identified in the N-terminal region of the adenovirus serotype 2 fiber protein at residues 2-10. It was shown that this signal can act independently of fiber protein, as it can direct a cytoplasmic protein, ␤-galactosidase, to the nuclei of HeLa cells. 7 A hydrophobic domain 10 FNPVYPY 16 is localized in the same part of fiber protein and we have noticed that it contains a NPXY motif involved in receptor-mediated endocytosis. [8] [9] [10] This article reports that a peptide made of 20 N-terminal amino acids of adenovirus fiber protein and polylysine (peptide I) is alone able to attach and direct plasmid DNA to the nucleus of transfected cells. Peptide I might be an interesting alternative to known vectors for gene transfer. It is at least as efficient as liposomes for gene transfer in cultured cells, and is safer and probably less immunogenic than viral vectors.
Results
Cell transfection with peptide I All experiments were carried out with HeLa cells transfected with a complex of peptide I and pGL3 plasmid bearing the luciferase gene. Peptide I, with the sequence A K R A R L S T S F N P V Y P Y E D E S -K 20 , contains 20 N-terminal residues of Ad3 fiber followed by 20 lysines (pLys). Optimal transfection conditions were established with respect to the interaction time with cells, the ratio of peptide I to DNA, and the NaCl concentration in the transfecting mixture. The optimal time of interaction of transfecting complexes with cells was 60-90 min. At 1 h transfection, the highest luciferase gene expression was observed at a ratio of peptide I to DNA of between 4 and 6 (w/w) and at 125 mm NaCl (Figure 1a ). Transgene expression could be observed at up to 6 days after transfection ( Figure 1b) .
Behavior of the peptide-DNA complex was analyzed on retardation gels. Theoretically, 322 ng of peptide is necessary for complete neutralization of 500 ng of plas- mid. Figure 2a shows that incubation with 250 ng of peptide results in retardation of DNA and the addition of 500 ng of peptide completely retards DNA migration, which is in agreement with the above considerations. The highest transfection efficiency was observed at a four-fold excess of peptide neutralizing charges over DNA (Figure 1a) , which confirms the observations of others that high gene transfer occurs in vitro under an excess of positive charges. 2, 11 Under these conditions, DNA seems to be protected against serum nucleases (Figure 2b) . However, the presence of 2-5% serum during 1 h transfection diminished the transfection efficiency several-fold and 10% serum completely abolished transfection with peptide I (results not shown), suggesting that factors other than serum nucleases inhibit transfection. A glycosaminoglycan, heparine, detaches peptide I from DNA which can then be recovered by phenol extraction (Figure 2b ). It is worth noting that serum contains significant amounts of glycosaminoglycans. 12 Phenol treatment alone extracted degraded DNA only (below 2200 bp), observed at a ratio of peptide to DNA below 1 ( Figure 2c ).
Effect of membrane permeabilizing agents
It has been reported that the addition of glycerol improves the transfection efficiency of transferrinpolylysine-DNA complexes. 13 Figure 3 shows that the addition of glycerol augments transfection carried out with peptide I, but not transfection with liposome. Similarly, inclusion of 0.1% DMSO in the transfection mixture improved the efficiency of transfection with peptide without exerting any toxic effect on cells (results not shown). These results suggest that the mechanism of translocation with peptide is different from that with liposome, and it might specifically mean that passage through the external cell membrane with peptide can be improved. It is worth noting that the transfection level obtained with two liposomes used (DOTAP and DOSPER) was much lower than that observed with peptide I. The time of transfection used here was 1 h as for peptide I, however, optimal results with liposomes appear to require a longer contact with cells (manufacturer's instructions).
Size of the transfecting complex Quasi-electric light scattering can be used to measure the size of large complexes, as well as the size distribution if there is formation of mixed populations. We used this technique to investigate the effect of time on the formation of transfecting complexes. The size was measured immediately after mixing or 1 h later (Table 1) . Complexes made by mixing the liposome DOTAP with plasmid DNA were approximately 110 nm in diameter and their size did not change with time. After mixing, complexes of DNA with peptide I were predominantly 300-400 nm in diameter. Complex size increased with time, as over 90% of complexes had diameters of 600-900 nm after 1 h. The size and distribution of peptide I complexes was similar for peptide to DNA ratios of 1 to 8.
We studied the effect of complex size upon transfection efficiency by using complexes formed for different lengths of time. Surprisingly, no significant effect was observed for preincubation times of 15-60 min (Figure 4) , which shows that even quite large aggregates (600-900 nm at 1 h) can be transfected with peptide I. Intracellular localization of peptide and DNA Confocal microscopy was utilized to determine the distribution of fluorescent peptide I within HeLa cells ( Figure 5 ). For comparison, cells were co-stained with propidium iodide, which binds to both RNA and DNA 14 and can therefore be used to visualize cytoplasm, nuclei and nucleoli. At 5 min after peptide addition cytoplasmic fluorescence was observed, indicating peptide entry into cells. At 10-60 min, the signal extended to nuclei and specifically became bright within nucleoli. This targeting of peptide to nucleoli is somewhat surprising. The peptide contains the NLS of the adenovirus fiber protein, but observations on trafficking of the fiber protein do not mention its being addressed to the nucleolus, once in the nucleus. 7 At times longer than 60 min, the signal within cells diminishes. Perhaps the peptide is transported back to the cytoplasm and exported at the cell periphery until the signal is totally lost. Results in Figure 5 were obtained with peptide concentrations two-fold higher (40 g/ml) than those used for DNA transfection experiments. When the concentration normally used for transfections was employed, accumulation of peptide within cells was slightly slower (results not shown).
To test the capacity of peptide I to carry DNA into cells, cells were examined by confocal microscopy following incubation with a comnplex of peptide I and YOYO-1-labeled plasmid DNA ( Figure 6 ). To show the relative entry of transfecting complexes into cells, images were collected at constant settings which were fixed to show maximum entry at 2 h (Figure 6a ). Similar to peptide I alone, plasmid associated with peptide I enters nuclei and becomes concentrated in nucleoli. However, entry of the peptide I-DNA complex is less rapid than for peptide I alone. Whereas peptide shows maximal entry at 60 min after addition and is not detectable in nuclei after 90 min, labeled DNA is maximal at 2-4 h after addition (Figure 6a ). By setting the confocal microscope at maximal sensitivity (Figure 6b ), labeled DNA can be first detected, and is present in nucleoli, at 90 min after transfection. Labeled DNA is observed in nucleoli for at least 48 h. At 90 min DNA is localized predominantly in the cytoplasm (Figure 6b ), whereas at 2-4 h it is observed mainly in nuclei and specifically in nucleoli (Figure 6a) . At 12 h, while the total signal has diminished, the cytoplasmic signal has increased relative to the nuclear signal ( Figure 6b ). Thus, unlike peptide alone, labeled plasmid DNA persits in nuclei for at least 48 h. It is relevant in this context that luciferase expression in transfected cells, while gradually diminishing, was observed for up to 6 days ( Figure 1b) . Entry of plasmid DNA into cells requires association with peptide; labeled plasmid DNA alone cannot be detected, as shown here 2 h after addition to cells, in an image obtained at the highest sensitivity ( Figure 6c ). These experiments show that peptide I serves as a vector for the uptake and nucleolar localization of exogenous DNA.
Efficient transfection requires each of the three domains present in peptide I
To study the effect of peptide I structure on DNA transfection, we used a series of peptides in which different parts of peptide I were deleted. bearing a NPXY motif involved in receptor-mediated endocytosis; [8] [9] [10] and a basic domain containing a stretch of lysines (pLys). The results presented in Table 2 show that shortening the pLys domain (IC) has only a modest negative effect on transfection efficiency and, predictably, it increases the amount of peptide needed for efficient transfer. The efficiency of transfection depends unconditionally upon the presence of fiber protein NLS as there is no transfection at all upon removal of NLS (peptide 1D). Removal of the hydrophobic domain in the middle of the N-terminus of the fiber protein (peptide IE) diminishes transfection efficiency. It is not clear, however, if lower transfection efficiency of IE stems only from the lack of the hydrophobic domain or also from the shortening of the distance between the NLS and pLys. The NLS might be partially hindered by the polylysine domain, which becomes bulky upon attaching DNA. Peptides K10 and K20 devoid both of the NLS and hydrophobic domains are unable to mediate transfection, similar to a peptide in which the pLys domain has been deleted (IA). These results show that each of the three domains of peptide I are necessary for efficient transfection.
To determine if there are sites of specific attachment of peptide I at the plasma membrane, we preincubated HeLa cells with peptide I at 4°C for 2 h. As a result, transfection with peptide I-DNA complex was totally inhibited (Figure 7a ). This indicates that absorption of peptide I is a saturable phenomenon and that the transfection mechanism perhaps involves receptor-mediated endocytosis, rather than adsorptive endocytosis which is less specific. When deleted peptides (shown in Table 1) were used for saturation of external sites, preincubation with peptide ID, which is devoid of NLS, led to rather weak inhibition of DNA transfer by peptide I (Figure 7b ). This is in contrast to the complete inhibition observed after preincubation with peptide I. Furthermore, when the peptide used for preincubation contained NLS, but was devoid of either the hydrophobic domain (IE) or of pLys (IA), strong inhibition was observed, again suggesting that it is predominantly the saturation of sites interacting with NLS which leads to the inhibition of gene transfer. In addition, the inhibition level observed with pLys alone suggests the presence of saturable sites interacting with cationic peptides.
To analyze how peptide I directs DNA into nuclei, the intracellular distribution of fluorescent DNA complexed with variants of peptide I was compared by confocal microscopy ( Figure 8 ). For each peptide, an equimolar quantity was complexed with DNA. Peptide IC is identical to peptide I, except that like the other peptides used in this comparison, it contains 10 consecutive lysine residues instead of 20. Both peptide IC and IE, in which the FNPVYPY hydophobic domain has been deleted, carry DNA into nucleoli. This is particularly evident in merged color images where nuclei appear yellow when the signal of labeled DNA (green) and propidium iodide (red) overlap. By contrast, neither peptide ID or K10, both of which lack NLS, enter nuclei when complexed with DNA. Both appear to be excluded from cells, and labeled DNA can sometimes be detected at the margin of the cell, as shown in merged color images. We conclude that NLS is critical to both the entry of the peptide I-DNA complex into cells and to the localization of DNA to nucleoli.
Figure 6 DNA complexed with peptide I enters the nucleoli of HeLa cells. Kinetics of the entry into cells of YOYO-1-labeled plasmid DNA ( * DNA) complexed with peptide I, as observed by confocal microscopy. Nuclei are visualized by counterstain with propidium iodide (right columns). (a) To show relative entry of transfecting complexes, images were collected at constant settings which were fixed to show maximum entry at 2 h. (b) For selected time-points images were enhanced to demonstrate DNA localization. (c) No signal was obtained when labeled DNA alone (DNA Control) was applied to cells for 2 h and images were collected at maximum sensitivity. Size bar 25 m.

Discussion
The outcome of gene therapy depends very much upon the efficiency of the vector. Viruses, transfer vehicles engineered by evolution, are the most efficient vectors. When constructing nonviral delivery systems, the goal is to achieve high transfectability by extracting or mimicking viral activities such as DNA condensation, interaction with membranes, membrane disruption, release from endosomes and nuclear targeting. Our article presents a vector made of a unique multivalent peptide which is able to attach and condense DNA, and to transfer DNA to the nucleus of the recipient cell. As a result, high gene transfer is observed in the target cell. The peptide is made of 20 N-terminal residues of adenovirus fiber protein, followed by polylysine. The sequence derived from adenovirus fiber protein contains a nuclear localization signal that is followed by a hydrophobic domain which bears a tyrosine-based endocytosis signal.
All three domains of peptide I cooperate during gene transfer. Peptide I appears to attach to cells by a saturable process that is followed by receptor-mediated endocytosis, since preincubation of cells with peptide I blocks translocation of this peptide and there is no translocation at 4°C. NLS of adenovirus protein is acting here in an autonomous way, guiding DNA to the nucleus of the target cell. However, it appears that in addition to its role in nuclear targeting, the region bearing NLS has a role in entry into the cell through the plasma membrane, since the removal of NLS not only completely abolishes gene transfer, but in addition abrogates the entry of the peptide-DNA complex into cells (Figure 8 ). This is a new role for this region of the adenovirus fiber protein, and has not been previously observed during adenovirus entry.
The hydrophobic domain FNPVYPY is also required for efficient transfer (Table 2 ), but not for entry into nuclei once DNA is within the cell (Figure 8 ). As the results obtained with confocal microscopy are qualitative, we cannot exclude the possibility that hydrophobic domain plays a role in cellular entry. This domain contains a tyrosine-based internalization signal NPXY involved in coated pit-mediated internalization of several non-G protein-coupled receptors. [8] [9] [10] However, the signal is found in the intracellular part of these receptors so it is plausible to think that it might exert its activity once the peptide passes the membrane. The translocation mechanism of peptide I through the cell membrane is not clear, but it is possible that the amino acids flanking NPVY are important for translocation. The hydrophobic domain FNPVYPY is composed of four bulky hydrophobic amino acids and three polar amino acids, which is reminiscent of a transmembrane domain and it might have a propen- sity to interact with and disturb membranes, which would facilitate DNA translocation. Similarly, amino acid residues crucial for the interaction of influenza hemagglutinin protein transmembrane domain with cell membrane lipids are large and hydrophobic. 15 However, an alternative explanation for the lower transfection efficiency of the peptide devoid of hydrophobic domain ( Table 2 ) might be that the shortening of the distance between the NLS and pLys hinders the interaction of peptide NLS with the cell nuclear transport system.
Additional transfection experiments with variants of peptide I containing scrambled NPVY signal could clarify this point. Polylysine is known not only to condense nucleic acids, but also to induce adsorptive endocytosis through interaction with membranes. 16, 17 We (this article) and others 2, 11 have observed that efficient gene transfer requires an excess of positive charges in the transfecting complex. Part of the positive charge obviously serves for attaching and electrostatically condensing nucleic acid. The other part is probably necessary for translocation through the anionic phospholipids present in all membranes 18 and/or for neutralization of some charged factors on the cell surface. Furthermore, it was recently shown that not only basic, but also hydrophobic regions in peptides bind DNA and thus improve gene transfer. 19 It has been shown for some peptide-mediated gene transfer that efficiency is related to the capacity to condense DNA into small particles. 20 On the other hand, in the case of gene transfer mediated by polyarginine only large aggregates (10 m) were successfully transfected. 21 In our hands, both small (350 nm) and larger (about 1000 nm) aggregates of DNA with peptide I transfected with similar efficiency (Figure 4 and Table 2 ).
Experiments aimed at finding which part of the transfecting pepetide is responsible for its interaction with the plasma membrane show that it is mainly the NLS domain and, to a lesser extent, the pLys domain which can saturate specific sites at 4°C and inhibit transfer with peptide I (Figure 6 ). However, it should be borne in mind that when the preincubated cells are transferred to 37°C for transfection, the inhibiting peptides may also enter the cell and compete with peptide I for sites necessary for DNA translocation further towards the nucleus. Furthermore, peptides containing pLys might compete with peptide I for DNA. Additional experiments are needed to resolve these questions.
Several attempts to use oligopeptides for intracellular entry and translocation have been described previously. Based on experiments in which the presence of a fusigenic peptide and polylysine in the transfection complex improved gene transfer during receptor-mediated endocytosis, 22, 23 two-peptide transfection systems were designed. 24, 25 In the first case a DNA-binding motif derived from histone protein was coupled to a lipophilic element (palmitoyl group) and mixed with a fusigenic peptide derived from hemagglutin protein of influenza virus. In the second case a DNA-binding motif, an analog of spermine, was mixed with a fusigenic peptide, which is an improved version of one derived from hemagglutin protein. An even simpler vector was obtained by fusing a polylysine domain with a cyclic RGD-containing sequence. This resulted in a polycation-DNA complex containing an integrin-binding domain, which uses a receptor (integrin)-mediated pathway of attachment and internalization for gene transfer. 26 A more rigorous approach to peptides as intracellular vehicles was shown by Sheldon et al, 17 who used the NLS of SV40 large T antigen to guide branched polypeptides containing a stretch of five lysines to the nucleus. The authors showed that after non-saturable binding to the cell the peptide enters by rather nonspecific adsorptive endocytosis and is targeted to the cell nucleus. These systems ensure that peptide with DNA enters the cell and localizes to nuclei. However, the efficiency of gene transfer with these systems is difficult to assess since no comparison with other transfection systems was provided.
The mechanism by which peptide I is internalized is different from one described for peptides derived from Drosophila homeoprotein 27 and from HIV-1 Tat protein. 28 These peptides are internalized by cells in culture and targeted to the nucleus by an energy-independent translocation process occurring at 4°C. The precise mechanism of this phenomenon is not clear.
In conclusion, we show here that a peptide containing an autonomous nuclear localization signal, an internalization motif and a polylysine domain is able to condense and attach plasmid DNA and efficiently to transfect cells in culture by successfully passing its cargo through plasma membranes and possibly endosomes and nuclear membranes. This peptide presents several advantages for gene therapy. There is no need to manipulate the cells to reach a high efficiency of transfection. The level of transfection is better than that observed for two liposomes tested. The peptide is rapidly eliminated by the target cell (in contrast with liposomes), is safer and probably less immunogenic than viral vectors. Because of its sensitivity to serum, the use of peptide I as an in vivo vector can be foreseen for local applications such as injection into muscle or solid tumors as well as for ex vivo applications.
Materials and methods
Cells, plasmid and peptides HeLa cells were grown at 37°C under 5% CO 2 in EMEM (BioWhittaker, Vervier, Belgium) supplemented with 10% fetal calf serum (Dominique Dutscher, Brumath, France). A luciferase reporter vector, plasmid pGL3 (Promega, Madison, WI, USA) was used for transfections. Peptides were obtained by solid phase synthesis, purified by reverse phase HPLC and stored dry at −20°C. Their identity, purity and integrity was checked periodically by electrospray mass spectrometry. Peptide I with 20 lysines was obtained at the IBS by Boc chemistry. The Boc group was used for ␣-amino protection and lysine side chains were protected with 2-chlorobenzyloxycarbonyl (ClZ). Peptide I with fluorescein conjugated at the first alanine was synthesized in the laboratory of Dr R Frank at ZMBH (Heidelberg, Germany). Peptides with 10 lysines were made at the EMBL (Heidelberg, Germany).
Transfections
Peptide I, 1.5-12 g in 50 l buffer A (20 mm Tris, pH 7.4, 150 mm NaCl), was preincubated with 1.5 g of the plasmid pGL3 in 250 l EMEM for 15-30 min at room temperature (RT). Transfections were performed in 24-well plates with 1.5 × 10 5 cells per well (approximately 50% confluency) for 1 h at 37°C. After 24 h, light emission was measured in cell lysates with a Lumat LB9501 apparatus (EG&G, Berthold, France) using the Luciferase Assay System (Promega). Liposomes DOTAP or DOSPER were used according to the manufacturer's instructions (Boehringer Mannheim, Mannheim, Germany) with transfections performed as above for 1 h.
Size of transfecting complexes
Portions of peptide I were mixed with 1.5 g of pGL3 in 300 l buffer A for 10 min at RT. DOTAP was mixed with 1.5 g of pGL3 at a DOTAP:DNA ratio of 2 or 4, in 300 l of buffer A for 10 min at RT. Quasi-elastic light scattering measurements were performed with an argon ion laser (Spectra Physics 1161) working at 488 nm and 150 mW in 90°scattering geometry. The spectra were accumulated for 200 s using a Malvern 7032 correlator (Malvern Instruments Ltd, Malvern, UK), and then repeated 1 h later. All spectra were found to be in the homodyne mode: the amplitudes of the intensity correlation function at zero delay time were consistent with the spatial coherence factor b obtained with a dilute latex suspension, namely b = 0.90. The hydrodynamic radii R H were calculated using the Malvern multimodal (Pike-Ostrowsky) procedure to characterize the principal decay rates of the field correlation function, together with the StokesEinstein relation R H = k B TQ 2 /(6⌫ 1 ), where ⌫ 1 is the leading decay rate, T the absolute temperature of the thermal bath (298K), Q the transfer wave vector and the solvent viscosity.
Peptide internalization
HeLa cells (10 5 ) grown on coverslips for 24 h were treated with 3% BSA in EMEM for 15 min at 37°C. Cells were washed twice with PBS, incubated with 40 g/ml fluorescein-labeled peptide I in 50 l EMEM and buffer A (5:1) for different times at 37°C, fixed with 2% paraformaldehyde in PBS for 20 min at 37°C, washed with PBS and stained with 1 g/ml propidium iodide in PBS for 5 min at RT. The coverslips were mounted on to a microscope slide in glycerol containing 1,4-diazabicyclo octane (Sigma, St Louis, MO, USA) and observed with a MRC600 laser scanning confocal microscope (Bio-Rad, Herts, UK).
Internalization of transfecting complexes pGL3 (5 g) in 500 l PBS was incubated with 0.5 l DMSO containing 1 mm YOYO-1 iodide (Molecular Probes, Eugene, OR, USA) for 1 h at RT. Excess dye was removed with a Nanosep 30 K column (Pall Filtron, Northborough, MA, USA) and the fluorescent DNA was recovered in about 50 l PBS. HeLa cells were grown on coverslips and treated with BSA as for peptide alone (above). Before exposure to cells, 2 g peptide I was preincubated with 0.5 g of labeled DNA in 50 l EMEM and buffer A (5:1) at RT for 15-30 min. Following 2 h incubation with cells, DNA-peptide complex was removed by washing cells twice with fresh medium and cells were maintained in growth medium at 37°C. The coverslips were fixed and mounted as for peptide alone (above). Similar results were obtained with freshly labeled DNA and labeled DNA stored at −20°C.
For comparison of internalization of pGL3 complexed with mutant peptides, cells were grown and treated with BSA, and DNA was labeled as described above. Before exposure to cells, 32.7 m of each peptide was preincubated with 1 g of freshly labeled DNA in 50 l EMEM and buffer A (5:1) at RT for 15-30 min. Cells were then incubated with DNA-peptide complex for 5 h at 37°C, fixed and stained with propidium iodide as described above.
